.Merck trumps incomes assumptions, rears purchases expectation on strong need for best medications like Keytruda CNBCMerck & Co. (MRK US) Beats Earnings Projections as Keytruda Purchases Increase BloombergMerck Supply: Pharma Giant Posts Strong End Results, But Outlook Falls Short Real estate investor's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck trumps revenue and also purchases requirements amid Keytruda advantage, yet offers mixed full-year overview MarketWatch.